Heart Muscle Injury Seen on MRI in Half of Those Who Recovered From Covid-19

A new study showed that approximately half of 148 hospitalized patients with Covid-19 infection and elevated troponin levels had at least some myocardial injury on cardiac magnetic resonance imaging (CMR) 2 months later.
Dr. Marianna Fontana of University College London and colleagues write: “Our results indicate that ongoing localized (regional) myocardial inflammation (heart muscle injury) persists in some patients in this subgroup of survivors of severe Covid-19 with troponin elevation, although less frequently than previously reported, and may represent an emerging clinical problem.”
The cardiac abnormalities identified in the cohort were classified as nonischemic in 26% (including myocarditis-like late gadolinium enhancement (LGE)), associated with ischemic heart disease (infarction or inducible ischemia) in 22%, and dual pathology in 6%.
Left ventricular (LV) function was normal in 89% of the 148 patients. Of the 17 patients with LV dysfunction (11% of patients), only 4 had an ejection fraction below 35%. Of the 9 patients whose LV dysfunction was associated with myocardial infarction, 6 had a known history of ischemic heart disease.

The Image Above: Basal and apical MRI views of an injured heart. Blue represents reduced blood flow, and orange represents good blood flow. Dark blue in the figure indicates the lower part of the heart, where myocardial blood flow is greatly reduced. The black-and-white angiogram shows that the vessel supplying blood to this part of the heart is blocked.
No patient with “myocarditis-pattern” LGE had regional wall motion abnormalities, and neither admission nor peak troponin values were a predictor of a myocarditis diagnosis.
The Glass Is Half Full
“The glass is half full” was the approach taken by author Graham D. Cole, who reported on Twitter that only 2 months after comparison with troponin-positive Covid-19 patients, approximately half the patients had no major cardiac abnormalities on MRI. Cole said, “We think this matters: even in a group that had been very ill with elevated troponin, absence of evidence of heart injury was common.”
The researchers conclude their report by saying: “We believe our data argue against the hypothesis that chronic inflammation, diffuse fibrosis, or long-term LV dysfunction is a dominant feature in Covid-19 survivors.”
Fortana said: “In an early ‘landmark’ study, two-thirds of patients who had recovered from Covid-19 had MRI evidence of abnormalities, with a high incidence of elevated T1 and T2 consistent with diffuse fibrosis and edema. Our findings from a larger, multicenter study with better controls show a low rate of heart failure and much less ongoing inflammation, which is reassuring.” She also noted that the different patterns of injury suggested different mechanisms at work, including the possibility “that at least some of the injury found may have existed beforehand, as people with heart disease are more likely to develop severe illness.”
The research group, including author Tushar Kotecta, reported that myocarditis-like injury was limited to three or fewer myocardial segments in 88% of cases without ventricular dysfunction, and that biventricular function did not differ from that of patients without myocarditis.
Fortana said: “We use the term ‘myocarditis-like,’ but we do not have histology. Our group actually suspects that much of this will be microvascular clotting (microangiopathic thrombosis). It is exciting that newer anticoagulation (clot prevention) strategies may be beneficial.”
Aloke V. Finn of the CVPath Institute in Gaithersburg, Maryland, wishes researchers would stop using the term myocarditis altogether to describe clinical or imaging findings in Covid-19. In an interview, Finn said: “MRI cannot diagnose myocarditis. It is a specific diagnosis that, as the researchers acknowledge, ideally requires histology.” Finn's group at CVPath published data showing pathological evidence of myocarditis after SARS-CoV-2 infection. He said: “As a clinician, when I think of myocarditis, I look at the echo and an LV gram and see whether there are wall motion abnormalities and elevated troponin. But if there are normal coronary arteries and everything is there, then I consider myocarditis in my differential diagnosis.” “However, in most of these cases, as the authors rightly point out, most patients did not really have what was required for a diagnosis of myocarditis.” He agrees with Fontana's suggestion that what MRI detected in these Covid-19 survivors was microthrombi.
“It is very likely that these findings are consistent with recent autopsy studies by my group and others in terms of detecting the presence of microthrombi. But we do not know for certain, because no one has previously studied their presence in the clinic, and we do not really know what microthrombi might look like on MRI.”
Summary and Conclusion
The 148 participants in the largest study to date investigating convalescent Covid-19 patients with elevated troponin were treated at one of six hospitals in London. Patients with abnormal troponin levels were offered cardiac MRI after discharge and compared with patients without Covid-19 and a control group of 40 healthy volunteers.
The patients' mean length of stay was 9 days, and 32% required ventilator support in an intensive care unit. Slightly more than half (57%) had hypertension, 7% had a previous myocardial infarction, 34% had diabetes, 46% had hypercholesterolemia, and 24% smoked. Mean body mass index was 28.5 kg /m2.
Follow-up MRI was performed a mean of 68 days after confirmation of the Covid-19 diagnosis.
Cole noted on Twitter that the findings were subject to both survivor bias and referral bias. “We did not scan frail patients whose doctors thought it was unlikely to inform management.”
Fontana said the findings tell us nothing about what happens in people who had Covid-19 but were not hospitalized, or those hospitalized without elevated troponin levels.
She added that what they suggest, especially if replicated, is a way forward to identify patients at higher or lower risk of long-term sequelae (residual impairments from the disease) and to inform strategies that could improve outcomes.
RELATED TOPICS
- Covid-19: Current Statistics for the World and Turkey
- Breaking News and Scientific Developments About Coronavirus
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.